FDA Inspection 703036 — Teva Pharmaceuticals USA, Inc

Teva Pharmaceuticals USA, Inc — FEI 3003092769

The FDA completed an inspection of Teva Pharmaceuticals USA, Inc on December 2, 2010 in Parsippany, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 2, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Parsippany, NJ (United States)

Citations

IDCFRDescription
440221 CFR 211.192Written record of investigation incomplete
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications